Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in BLTE held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | Darwin Global Management, Ltd. | 3.1M | $456.1M | +1.0% | 7.627% | 12.10% |
| 2 | Paradigm Biocapital Advisors LP | 1.1M | $177.7M | β | 2.781% | 3.63% |
| 3 | UBS Group AG | 768K | $122.5M | +496.8% | 1.917% | 0.02% |
| 4 | RTW INVESTMENTS, LP | 715K | $114.1M | 0.0% | 1.784% | 1.13% |
| 5 | MILLENNIUM MANAGEMENT LLC | 570K | $90.9M | +2.0% | 1.422% | 0.06% |
| 6 | Holocene Advisors, LP | 494K | $78.8M | +488.2% | 1.234% | 0.19% |
| 7 | EVENTIDE ASSET MANAGEMENT, LLC | 358K | $57.0M | -6.6% | 0.892% | 0.94% |
| 8 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 304K | $48.5M | +30.0% | 0.758% | 0.57% |
| 9 | MORGAN STANLEY | 201K | $32.1M | +619.0% | 0.502% | 0.00% |
| 10 | PERCEPTIVE ADVISORS LLC | 152K | $24.2M | -63.3% | 0.379% | 0.48% |
| 11 | Patient Square Capital LP | 117K | $18.6M | β | 0.291% | 3.30% |
| 12 | GOLDMAN SACHS GROUP INC | 106K | $16.8M | +136.6% | 0.263% | 0.00% |
| 13 | MPM Oncology Impact Management LP | 88K | $14.0M | +0.3% | 0.220% | 1.08% |
| 14 | Affinity Asset Advisors, LLC | 65K | $10.4M | +225.0% | 0.162% | 0.60% |
| 15 | FRED ALGER MANAGEMENT, LLC | 63K | $10.0M | -21.2% | 0.156% | 0.04% |
| 16 | PFM Health Sciences, LP | 59K | $9.5M | +199.8% | 0.148% | 0.94% |
| 17 | RENAISSANCE TECHNOLOGIES LLC | 52K | $8.3M | β | 0.130% | 0.01% |
| 18 | Longaeva Partners L.P. | 33K | $5.3M | β | 0.084% | 0.28% |
| 19 | TD ASSET MANAGEMENT INC | 33K | $5.3M | β | 0.083% | 0.00% |
| 20 | BNP PARIBAS ARBITRAGE, SA | 33K | $5.2M | +1228.6% | 0.081% | 0.00% |
| 21 | ADAR1 Capital Management, LLC | 27K | $4.3M | -32.5% | 0.067% | 0.27% |
| 22 | Artia Global Partners LP | 25K | $4.0M | +38.9% | 0.062% | 0.81% |
| 23 | Quadrature Capital Ltd | 24K | $3.8M | -4.5% | 0.059% | 0.04% |
| 24 | Aquatic Capital Management LLC | 20K | $3.2M | β | 0.051% | 0.09% |
| 25 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 20K | $3.1M | β | 0.049% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in BLTE β a direct measure of their conviction.
Filings activity in BLTE during Q1 2026, grouped by how each filer changed its position.
8 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 75 | +10% | 24.56% | +3.78 pp | $1.36B | +18% |
| Q4 2025 | 68 | +100% | 20.78% | +17.72 pp | $1.15B | +579% |
| Q3 2025 | 34 | +79% | 3.06% | +2.98 pp | $169M | +3656% |
| Q2 2025 | 19 | +0.0% | 0.08% | 0.09 pp | $5M | 53% |
| Q1 2025 | 19 | 17% | 0.17% | 0.15 pp | $10M | 47% |
| Q4 2024 | 23 | +44% | 0.32% | +0.25 pp | $18M | +383% |
| Q3 2024 | 16 | +33% | 0.07% | 0.08 pp | $4M | 55% |
| Q2 2024 | 12 | β | 0.15% | β | $8M | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying BLTE stock.
Based on Q1 2026 13F filings, institutional ownership of Belite Bio, Inc stands at 24.6%, held across 75 reporting institutions.
Darwin Global Management, Ltd. is the largest reported institutional holder of BLTE, with approximately 3,057,412 shares worth $0.46B as of Q1 2026.
Yes β 2 widely-followed marquee investors appear among the top 25 institutional holders of BLTE, including MILLENNIUM MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC.
Our composite Smart Money Score for BLTE is 67 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
29 institutions opened new positions in BLTE during Q1 2026, while 22 fully exited. 25 added to existing positions and 21 trimmed.
BLTE institutional ownership rose by 3.78 percentage points quarter-over-quarter, with a net change of +7 holders.
The top 10 institutions account for 88.4% of all reported 13F value in BLTE, and the top 25 account for 97.3%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Belite Bio, Inc (BLTE) Institutional Ownership